$LVO
LiveOne, Inc. Stock $lvo

$lvo Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923032626 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$31.25M	$28.53M	$23.53M
YoY Change	14.41%	21.23%	7.33%
Cost Of Revenue	$23.27M	$20.55M	$13.74M
YoY Change	20.17%	49.52%	-14.39%
Gross Profit	$7.978M	$7.981M	$9.790M
YoY Change	0.39%	-18.48%	66.7%
Gross Profit Margin	25.53%	27.98%	41.6%
Selling, General & Admin	$7.394M	$8.605M	$6.837M
YoY Change	20.36%	25.86%	-41.31%
% of Gross Profit	92.68%	107.82%	69.84%
Research & Development	$694.0K	$1.439M	$1.240M
YoY Change	-32.95%	16.05%	-16.78%
% of Gross Profit	8.7%	18.03%	12.67%
Depreciation & Amortization	$800.0K	$800.0K	$2.700M
YoY Change	-27.27%	-70.37%	11.8%
% of Gross Profit	10.03%	10.02%	27.58%
Operating Expenses	$8.088M	$10.04M	$8.077M
YoY Change	12.68%	24.35%	-48.02%
Operating Profit	-$753.0K	-$2.515M	-$987.0K
YoY Change	31.18%	154.81%	-89.79%
Interest Expense	-$1.279M	-$780.0K	-$2.576M
YoY Change	-42.39%	-69.72%	141.2%
% of Operating Profit
Other Income/Expense, Net	-$1.486M	-$5.433M	-$2.393M
YoY Change	-24.3%	127.04%	1259.66%
Pretax Income	-$2.239M	-$7.948M	-$29.00K
YoY Change	20254.55%	27306.9%	-99.81%
Income Tax	-$15.00K	-$21.00K	$3.380M
% Of Pretax Income
Net Earnings	-$1.574M	-$7.580M	-$3.409M
YoY Change	-38.23%	122.35%	-77.63%
Net Earnings / Revenue	-5.04%	-26.57%	-14.49%
Basic Earnings Per Share	-$0.03	-$0.09	-$0.04
Diluted Earnings Per Share	-$0.02	-$0.09	-$0.04
COMMON SHARES
Basic Shares Outstanding	91.18M	90.20M shares	84.29M shares
Diluted Shares Outstanding			84.71M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.248M	$3.606M	$7.151M
YoY Change	-24.29%	-49.57%	-56.6%
Cash & Equivalents	$6.248M	$3.606M	$7.151M
Short-Term Investments
Other Short-Term Assets	$1.762M	$3.164M	$3.109M
YoY Change	-41.13%	1.77%	-56.33%
Inventory	$2.092M	$2.280M	$2.201M
Prepaid Expenses
Receivables	$16.06M	$17.18M	$12.96M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$26.16M	$26.23M	$25.42M
YoY Change	-5.66%	3.21%	-38.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.634M	$2.990M	$4.091M
YoY Change	-1.17%	-26.91%	-26.63%
Goodwill	$23.38M	$23.38M	$23.38M
YoY Change	0.0%	0.0%
Intangibles	$12.54M	$12.64M	$12.62M
YoY Change	11.14%	0.14%
Long-Term Investments
YoY Change
Other Assets	$122.0K	$157.0K	$579.0K
YoY Change	-75.94%	-72.88%
Total Long-Term Assets	$39.67M	$39.17M	$40.67M
YoY Change	2.13%	-3.7%	-15.31%
TOTAL ASSETS
Total Short-Term Assets	$26.16M	$26.23M	$25.42M
Total Long-Term Assets	$39.67M	$39.17M	$40.67M
Total Assets	$65.83M	$65.40M	$66.09M
YoY Change	-1.11%	-1.04%	-26.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.31M	$10.85M	$19.04M
YoY Change	-43.61%	-43.02%	-9.05%
Accrued Expenses	$13.26M	$13.88M	$9.193M
YoY Change	144.2%	50.96%	-68.39%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$2.949M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$7.694M	$7.694M	$315.0K
YoY Change	51193.33%	2342.54%	-86.25%
Total Short-Term Liabilities	$47.68M	$46.66M	$44.79M
YoY Change	0.55%	4.16%	-24.31%
LONG-TERM LIABILITIES
Long-Term Debt	$941.0K	$1.055M	$26.18M
YoY Change	-96.44%	-95.97%	-1.04%
Other Long-Term Liabilities	$7.406M	$8.906M	$4.928M
YoY Change	58.45%	80.72%	315.16%
Total Long-Term Liabilities	$7.406M	$8.906M	$31.11M
YoY Change	-76.2%	-71.37%	12.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.68M	$46.66M	$44.79M
Total Long-Term Liabilities	$7.406M	$8.906M	$31.11M
Total Liabilities	$56.64M	$57.08M	$76.24M
YoY Change	-28.19%	-25.13%	-12.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$236.0M	-$233.6M	-$215.9M
YoY Change	8.01%	8.2%
Common Stock	$91.00K	$91.00K	$88.00K
YoY Change	3.41%	3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.863M	$3.750M	$1.938M
YoY Change	99.33%	93.5%
Treasury Stock Shares
Shareholders Equity	-$4.689M	-$5.978M	-$10.15M
YoY Change
Total Liabilities & Shareholders Equity	$65.83M	$65.40M	$66.09M
YoY Change	-1.11%	-1.04%	-26.22%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.574M	-$7.580M	-$3.409M
YoY Change	-38.23%	122.35%	-77.63%
Depreciation, Depletion And Amortization	$800.0K	$800.0K	$2.700M
YoY Change	-27.27%	-70.37%	11.8%
Cash From Operating Activities	$3.849M	-$1.265M	-$6.771M
YoY Change	77.13%	-81.32%	-13.34%
INVESTING ACTIVITIES
Capital Expenditures	$980.0K	$1.170M	-$493.0K
YoY Change	27.11%	-337.32%	-47.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$980.0K	-$1.170M	-$493.0K
YoY Change	27.11%	137.32%	-47.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-227.0K	1.017M	3.309M
YoY Change	-24.33%	-69.27%	323.69%
NET CHANGE
Cash From Operating Activities	3.849M	-1.265M	-6.771M
Cash From Investing Activities	-980.0K	-1.170M	-493.0K
Cash From Financing Activities	-227.0K	1.017M	3.309M
Net Change In Cash	2.642M	-1.418M	-3.955M
YoY Change	139.75%	-64.15%	-50.38%
FREE CASH FLOW
Cash From Operating Activities	$3.849M	-$1.265M	-$6.771M
Capital Expenditures	$980.0K	$1.170M	-$493.0K
Free Cash Flow	$2.869M	-$2.435M	-$6.278M
YoY Change	104.64%	-61.21%	-8.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000
CY2023Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5000
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5000
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5000
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	17230
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	17230
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	16177
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	16177
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90906798
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90906798
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89632161
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89632161
	lvo	Stock Issued During The Period Shares Settlement Of Earnout StockIssuedDuringThePeriodSharesSettlementOfEarnout	414137
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1000000
	lvo	Stock Issued During Period Shares Settlement Of Liabilities StockIssuedDuringPeriodSharesSettlementOfLiabilities	1397918
CY2022Q3	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	100000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	0
CY2020Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38249
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	us-gaap	Bridge Loan BridgeLoan	4726000	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0657263
	dei	Entity Address Address Line1 EntityAddressAddressLine1	269 S. Beverly Dr., Suite #1450
	dei	Entity Address City Or Town EntityAddressCityOrTown	Beverly Hills
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90212
	dei	City Area Code CityAreaCode	310
	dei	Local Phone Number LocalPhoneNumber	601-2505
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	LVO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	91175153
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3606000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8409000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	205000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	240000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17184000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13658000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	2280000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	2596000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2959000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2823000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	26234000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	27726000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2990000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3325000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	23379000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	23379000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12640000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11035000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	423000	usd
CY2023Q3	us-gaap	Assets Assets	65400000	usd
CY2023Q1	us-gaap	Assets Assets	65888000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	24993000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22772000	usd
CY2023Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	13092000	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	12826000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	694000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	15000	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	880000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	992000	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q3	us-gaap	Bridge Loan BridgeLoan	0	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3148000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	46659000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	44479000	usd
CY2023Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	7000000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1055000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	148000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	161000	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	127000	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	376000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8906000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9578000	usd
CY2023Q3	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	332000	usd
CY2023Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	332000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	57079000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	62074000	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	4827000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	4827000	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	17230000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	16177000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	91000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	90000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	214069000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	209151000	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	3750000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2162000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-233618000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-224269000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5978000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1013000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	9472000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	0	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3494000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1013000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65400000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65888000	usd
CY2023Q3	us-gaap	Revenues Revenues	28528000	usd
CY2022Q3	us-gaap	Revenues Revenues	23532000	usd
	us-gaap	Revenues Revenues	56295000	usd
	us-gaap	Revenues Revenues	46755000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	20547000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	13742000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	39748000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	29125000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2253000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2362000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4157000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4727000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1439000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1240000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2685000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2857000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6352000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4475000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11760000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6685000	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1356000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1356000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	452000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1344000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	699000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2755000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	31043000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	24519000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	59049000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	47505000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2515000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-987000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2754000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-750000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-780000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2576000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2198000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3573000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4653000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	183000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3412000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2289000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5433000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2393000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5610000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1284000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7948000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3380000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8364000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2034000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-21000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-7927000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3409000	usd
	us-gaap	Profit Loss ProfitLoss	-8422000	usd
	us-gaap	Profit Loss ProfitLoss	-2061000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-347000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-347000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-7580000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3409000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8075000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2061000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87222168
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84709971
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87097201
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84189970
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1013000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	484000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	626000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	393000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1013000	usd
CY2023Q2	lvo	Net Income Loss Including Noncontrolling Interest NetIncomeLossIncludingNoncontrollingInterest	-515000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2290000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1767000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	917000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	628000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	4752000	usd
CY2023Q3	us-gaap	Stockholders Equity Note Spinoff Transaction StockholdersEquityNoteSpinoffTransaction	0	usd
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	usd
CY2023Q3	lvo	Reclassifications Of Common Stock Warrants ReclassificationsOfCommonStockWarrants	5896000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	521000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8000	usd
CY2023Q3	lvo	Stock Issued During Period Value Preferred Shares StockIssuedDuringPeriodValuePreferredShares	1053000	usd
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	575000	usd
CY2023Q3	lvo	Net Income Loss Including Noncontrolling Interest NetIncomeLossIncludingNoncontrollingInterest	-7927000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3494000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10916000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	788000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	997000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1348000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9777000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1396000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2000	usd
CY2022Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1142000	usd
CY2022Q3	lvo	Stock Issued During Period Value Settlement Of Earnout StockIssuedDuringPeriodValueSettlementOfEarnout	493000	usd
CY2022Q3	lvo	Stock Issued During Period Value Settlement Of Accrued Expenses StockIssuedDuringPeriodValueSettlementOfAccruedExpenses	945000	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	941000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3409000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10149000	usd
	us-gaap	Profit Loss ProfitLoss	-8422000	usd
	us-gaap	Profit Loss ProfitLoss	-2061000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2298000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4611000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	269000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	200000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3594000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5763000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2184000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1110000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1261000	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-3977000	usd
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	571000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	174000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2220000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6158000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	132000	usd
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1356000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3658000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-729000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	412000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	992000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-316000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	270000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-221000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-155000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-112000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-144000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1548000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-6767000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2016000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1890000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6797000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1264000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1254000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	536000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	24000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1800000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1278000	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	3000000	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	-0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1700000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	113000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	-0	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	4376000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	-0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	426000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	300000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1588000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1938000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2993000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2312000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4838000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8649000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13154000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3811000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7391000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	641000	usd
	us-gaap	Interest Paid Net InterestPaidNet	825000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	4752000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	usd
CY2023Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	0	usd
CY2022Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	2845000	usd
	lvo	Stock Issued During Period Value Settlement Of Earnout StockIssuedDuringPeriodValueSettlementOfEarnout	0	usd
	lvo	Stock Issued During Period Value Settlement Of Earnout StockIssuedDuringPeriodValueSettlementOfEarnout	493000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1142000	usd
	lvo	Stock Issued During Period Value Settlement Of Accrued Expenses StockIssuedDuringPeriodValueSettlementOfAccruedExpenses	0	usd
	lvo	Stock Issued During Period Value Settlement Of Accrued Expenses StockIssuedDuringPeriodValueSettlementOfAccruedExpenses	945000	usd
CY2023Q3	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	5896000	usd
CY2022Q3	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	1604000	usd
	us-gaap	Stock Issued1 StockIssued1	322000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	851000	usd
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	usd
	lvo	Fair Value Of Intangible Assets Acquired With Common Shares FairValueOfIntangibleAssetsAcquiredWithCommonShares	917000	usd
	lvo	Fair Value Of Intangible Assets Acquired With Common Shares FairValueOfIntangibleAssetsAcquiredWithCommonShares	0	usd
	lvo	Fair Value Of Options To Employees Capitalized As Software FairValueOfOptionsToEmployeesCapitalizedAsSoftware	0	usd
	lvo	Fair Value Of Options To Employees Capitalized As Software FairValueOfOptionsToEmployeesCapitalizedAsSoftware	26000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3800000	usd
	us-gaap	Profit Loss ProfitLoss	-8400000	usd
CY2023Q3	lvo	Working Capital WorkingCapital	20400000	usd
CY2023Q3	lvo	Potential Financing Amount PotentialFinancingAmount	150000000	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	800000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of the Company’s condensed consolidated financial statements in conformity with the United States of America (“US”) generally accepted accounting principles (“GAAP”) requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, inventory calculations and reserves, the fair value of the Company’s equity-based compensation awards and convertible debt and debenture instruments, fair values of derivatives, and contingencies. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. Given the overall uncertainty surrounding the COVID-<em style="font: inherit;">19</em> pandemic, there is a reasonable possibility that actual results could differ from those estimates and such differences could be material to the financial position and results of operations, specifically in assessing when the collectability of revenue related consideration is probable, and the impairment assessment of goodwill, indefinite lived assets or long-lived assets that are depreciated or amortized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	100000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281667
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3525191
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5960593
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-7580000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8075000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	628000	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1254000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8208000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9329000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87222168
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87097201
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3606000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8409000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	205000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	240000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3811000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8649000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	17886000	usd
CY2022Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	14228000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	702000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	570000	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	17184000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	13658000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Concentration of Credit Risk</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the <em style="font: inherit;">$250,000</em> amount insured by the Federal Deposit Insurance Corporation. The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk with respect to such cash and cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28528000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23532000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56295000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46755000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	992000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	392000	usd
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	280000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	880000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23511000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22250000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20521000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18925000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2990000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3325000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	800000	usd
	us-gaap	Depreciation Depreciation	1600000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	900000	usd
	us-gaap	Depreciation Depreciation	1800000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	23379000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Goodwill Goodwill	23379000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	38727000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-30724000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8003000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36422000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-30024000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6398000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2700000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1400000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	930000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1807000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1629000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1024000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	513000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2100000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8003000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10846000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10960000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13878000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11539000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	269000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	273000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	24993000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	22772000	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	1749000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	163000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	694000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	15000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1055000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	148000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	273000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P1Y
	us-gaap	Operating Lease Cost OperatingLeaseCost	392000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	312000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	70000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	27000	usd
	us-gaap	Lease Cost LeaseCost	462000	usd
	us-gaap	Lease Cost LeaseCost	339000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	259000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	423000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	269000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	161000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	269000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	434000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	153000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	140000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	293000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	269000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.085	pure
CY2023Q3	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q1	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	174000	usd
CY2023Q3	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	4535000	usd
CY2023Q1	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	3788000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	4115000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5616000	usd
CY2023Q3	lvo	Other Liabilities Noncurrent Miscellaneous OtherLiabilitiesNoncurrentMiscellaneous	256000	usd
CY2023Q1	lvo	Other Liabilities Noncurrent Miscellaneous OtherLiabilitiesNoncurrentMiscellaneous	0	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8906000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9578000	usd
CY2023Q3	us-gaap	Prepaid Royalties PrepaidRoyalties	300000	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.05	pure
CY2023Q3	lvo	Stock Authorized StockAuthorized	510000000
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	lvo	Stock Repurchase Program Increase In Authorized Amount StockRepurchaseProgramIncreaseInAuthorizedAmount	2000000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1009744
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	2000000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1600000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1900000	usd
CY2023Q3	lvo	Stock Issued To Noncontrolling Owners StockIssuedToNoncontrollingOwners	4300000
CY2023Q3	lvo	Stock Issued To Noncontrolling Owners StockIssuedToNoncontrollingOwners	4300000
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1500000	usd
CY2023Q3	lvo	Stock Issued To Noncontrolling Owners StockIssuedToNoncontrollingOwners	3100000
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	2400000	usd
CY2023Q3	us-gaap	Revenues Revenues	28528000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-7927000	usd
CY2022Q3	us-gaap	Revenues Revenues	23532000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3409000	usd
	us-gaap	Revenues Revenues	56295000	usd
	us-gaap	Profit Loss ProfitLoss	-8422000	usd
	us-gaap	Revenues Revenues	46755000	usd
	us-gaap	Profit Loss ProfitLoss	-2061000	usd

Files In Submission

Name	View Source	Status
0001437749-23-032626-index-headers.html	Edgar Link	pending
0001437749-23-032626-index.html	Edgar Link	pending
0001437749-23-032626.txt	Edgar Link	pending
0001437749-23-032626-xbrl.zip	Edgar Link	pending
ex_580040.htm	Edgar Link	pending
ex_580041.htm	Edgar Link	pending
ex_580042.htm	Edgar Link	pending
ex_580043.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lvo-20230930.xsd	Edgar Link	pending
lvo20230930_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
lvo-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lvo-20230930_lab.xml	Edgar Link	unprocessable
lvo-20230930_def.xml	Edgar Link	unprocessable
lvo-20230930_pre.xml	Edgar Link	unprocessable
lvo20230930_10q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LVO
LiveOne, Inc. Stock $lvo

2023 Q4 Form 10-Q Financial Statement

#000143774923032626 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LVO LiveOne, Inc. Stock $lvo

2023 Q4 Form 10-Q Financial Statement

#000143774923032626 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LVO
LiveOne, Inc. Stock $lvo